Moderna
MRNA
#1016
Rank
โ‚น2.303 T
Marketcap
โ‚น5,806
Share price
1.40%
Change (1 day)
117.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น280.77 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2025 the company made an earning of -โ‚น265.45 Billion, an increase over its 2024 earnings that were of -โ‚น344.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น280.77 Billion5.77%
2025 -โ‚น265.45 Billion-23.03%
2024 -โ‚น344.85 Billion-8.22%
2023 -โ‚น375.75 Billion-140.65%
2022 โ‚น924.33 B-27.81%
2021 โ‚น1.280 T-1911.15%
2020 -โ‚น70.7 Billion44.7%
2019 -โ‚น48.86 Billion28.63%
2018 -โ‚น37.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.500 T-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.519 T-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น1.265 T-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.57 Billion-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.33 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น4.02 Billion-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น83.70 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น33.21 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA